Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,017Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Amneal Pharmaceuticals

02 32AstraZeneca

03 2Lupin Ltd

04 1MSN Laboratories

05 1Par Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAXAGLIPTIN; METFORMIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 5MG;500MG

Packaging :

Approval Date :

Application Number : 205942

Regulatory Info :

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAXAGLIPTIN; METFORMIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 2.5MG;1000MG

Packaging :

Approval Date :

Application Number : 205942

Regulatory Info :

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAXAGLIPTIN; METFORMIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN;METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 5MG;1000MG

Packaging :

Approval Date :

Application Number : 205942

Regulatory Info :

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Saxagliptin 5Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Saxagliptin 2,5Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 2.5 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin; Metformin

Brand Name : Komboglyze

Dosage Form : Saxagliptin + Metformin 2.5 + 850Mg 56 Combined Oral Use

Dosage Strength : 56 cpr riv 2.5 mg + 850 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin; Metformin

Brand Name : Komboglyze

Dosage Form : Saxagliptin + Metformin 2.5 + 1.000Mg 56 Combined Oral Use

Dosage Strength : 56 cpr riv 2.5 mg + 1,000 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 5 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin

Brand Name : Onglyza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 5 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin; saxagliptin

Brand Name : Komboglyze

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5MG; 1000MG

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin; saxagliptin

Brand Name : Komboglyze

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5MG; 1000MG

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin; saxagliptin

Brand Name : Komboglyze

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5MG; 850MG

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Metformin; saxagliptin

Brand Name : Komboglyze

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 2.5MG; 850MG

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

saxagliptin; Dapagliflozin

Brand Name : Qtern

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 05MG; 10MG

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE

Dosage Form : TABLET; ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 211532

Regulatory Info :

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE

Dosage Form : TABLET; ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 211532

Regulatory Info :

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DAPAGLIFLOZIN; SAXAGLIPTIN

Brand Name : DAPAGLIFLOZIN AND SAXAGLIPTIN

Dosage Form : TABLET; ORAL

Dosage Strength : 10MG/5MG

Packaging :

Approval Date :

Application Number : 211533

Regulatory Info :

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

SAXAGLIPTIN

Brand Name : SAXAGLIPTIN

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number : 205959

Regulatory Info :

Registration Country : USA

blank